About: Starting a Biologic Therapy in IBD Patients Amid COVID-19: Hold, Careful Monitoring, or Testing?   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

AttributesValues
value
  • Starting a Biologic Therapy in IBD Patients Amid COVID-19: Hold, Careful Monitoring, or Testing?
Subject
  • Biotechnology
  • Zoonoses
  • Viral respiratory tract infections
  • COVID-19
  • Pharmacy
  • Life sciences industry
  • Biopharmaceuticals
  • Occupational safety and health
  • Pharmaceutical industry
  • Biotechnology products
  • Newspaper content
  • Freedom of expression
  • Letters (message)
  • Public opinion
  • Specialty drugs
part of
is hasSource of
is resource representing a document's title of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software